NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-165-2020-0-US-01 HLA CLASS II-RESTRICTED DRB T CELL RECEPTORS AGAINST RAS WITH G12D MUTATION US 63/050,931 Abandoned
NHLBI E-206-2020-0-US-01 Devices And Methods For Cerclage Of Luminal Systems US 63/050,270 Abandoned
NEI E-059-2020-0-US-01 CELL LINES THAT PRODUCE HUMAN RETINOSCHISIN PROTEINS AND USES THEREOF US 63/049,749 Abandoned
NIAID E-531-2013-2-US-07 EPSTEIN-BARR VIRUS VACCINES US DIV 16/922,322 12005115 Issued PDF
NHLBI E-143-2021-0-US-01 TISSUE EXCISION, CUTTING, AND REMOVAL SYSTEMS AND METHODS US 63/047,995 Abandoned
NIAID E-198-2025-0-US-07 VIRAL SEROLOGY ASSAYS US 63/047,644 Expired
NEI E-071-2020-0-US-01 COMPOUND EMBODIMENTS FOR TREATING RETINAL DEGENERATION AND METHOD EMBODIMENTS OF MAKING AND USING THE SAME US 63/047,858 Abandoned
NCI E-239-2017-0-KR-13 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS KR National Stage 10-2020-7019185 Pending
NIAID E-154-2017-0-US-04 NEUTRALIZING ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN AND THEIR USE US National Stage 16/959,644 11976109 Issued PDF
NCI E-103-2019-0-CN-05 MONOCLONAL ANTIBODIES THAT BIND EGFRVIII AND THEIR USE CN National Stage 202080055447.2 Issued
NCI E-230-2012-0-JP-60 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 JP DIV 2020-114090 Issued
NCI E-103-2019-0-PCT-02 MONOCLONAL ANTIBODIES THAT BIND EGFRVIII AND THEIR USE PCT PCT PCT/US2020/040544 Expired
NCI E-103-2019-0-EP-06 MONOCLONAL ANTIBODIES THAT BIND EGFRVIII AND THEIR USE EP National Stage 20745396.0 Pending
NCI E-103-2019-0-JP-10 MONOCLONAL ANTIBODIES THAT BIND EGFRVIII AND THEIR USE JP National Stage 2022-500090 Pending
NCI E-103-2019-0-IN-09 MONOCLONAL ANTIBODIES THAT BIND EGFRVIII AND THEIR USE IN National Stage 202217002368 Pending
NCI E-103-2019-0-IL-08 MONOCLONAL ANTIBODIES THAT BIND EGFRVIII AND THEIR USE IL National Stage 289488 Abandoned
NCI E-103-2019-0-AU-03 MONOCLONAL ANTIBODIES THAT BIND EGFRVIII AND THEIR USE AU National Stage 2020299382 Pending
NCI E-103-2019-0-CA-04 MONOCLONAL ANTIBODIES THAT BIND EGFRVIII AND THEIR USE CA National Stage 3142833 Pending
NCI E-103-2019-0-SG-14 MONOCLONAL ANTIBODIES THAT BIND EGFRVIII AND THEIR USE SG National Stage 11202114486Y Abandoned
NCI E-103-2019-0-MX-12 MONOCLONAL ANTIBODIES THAT BIND EGFRVIII AND THEIR USE MX National Stage MX/a/2022/000174 Pending
NCI E-103-2019-0-KR-11 MONOCLONAL ANTIBODIES THAT BIND EGFRVIII AND THEIR USE KR National Stage 10-2022-7003667 Pending
NCI E-103-2019-0-EA-15 MONOCLONAL ANTIBODIES THAT BIND EGFRVIII AND THEIR USE EA National Stage 202290208 Pending
NINDS E-120-2020-0-US-01 DUAL-TUNED OPTICALLY CONTROLLED ON-COIL AMPLIFIER FOR HIGH-FIELD MAGNETIC RESONANCE IMAGING SYSTEMS US 63/046,896 Abandoned
NCI E-079-2020-1-US-01 IMMUNOTHERAPY WITH COMBINATION THERAPY COMPRISING AN IMMUNOTOXIN US 63/046,738 Abandoned
NIAID E-187-2020-0-US-01 SARS-CoV-2 VACCINE US 63/046,603 Abandoned
NCI E-227-2017-0-US-04 PURIFICATION AND LABELING OF EXTRACELLULAR VESICLES USING A MIXED MODE RESIN COMPOSITION US National Stage 16/959,071 12083448 Issued PDF
NCI E-494-2013-0-CN-20 Methods of Preparing Anti-human Papillomavirus Antigen T Cells CN DIV 202010606868.1 Pending
NCI E-135-2019-0-TW-03 T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53 TW ORD 109121744 Issued
NCI E-239-2017-0-RU-01 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS RU EA 202091335 Issued
NCI E-239-2017-0-BY-01 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS BY EA 202091335 Issued
NCI E-239-2017-0-EA-08 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS EA National Stage 202091335 Issued
NHGRI E-104-2019-0-PCT-02 SYNTHETIC GENES FOR THE TREATMENT OF PROPIONIC ACIDEMIA CAUSED BY MUTATIONS IN PROPIONYL-COA CARBOXYLASE ALPHA PCT PCT PCT/US2020/039901 Expired
NCI E-135-2019-0-PCT-02 T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53 PCT PCT PCT/US2020/039785 Expired
NCATS E-038-2021-0-US-01 Modified FGF-1 Formulation and Manufacturing US 63/044,985 Abandoned
NCI E-142-2014-0-US-06 METHODS OF TREATMENTS USING ANTIGEN-BINDING PROTEINS TARGETING CD56 US DIV 16/912,291 12018077 Issued PDF
NIAID E-139-2006-0-US-67 DEVELOPMENT OF DENGUE VIRUS VACCINE COMPONENTS US DIV 16/912,359 11332722 Issued PDF
NEI E-192-2014-1-US-08 Surgical Tool And Method For Soft Ocular Tissue Transplantation US CON 16/910,388 11723799 Issued PDF
NCI E-021-2015-0-JP-33 Anti-CD70 Chimeric Antigen Receptors JP DIV 2020-109158 Issued
NCI E-208-2015-0-US-08 THALIDOMIDE ANALOGS AND METHODS OF USE US CON 16/910,708 10836721 Issued PDF
NCI E-210-2020-0-PCT-01 AGENTS FOR SENSITIZING SOLID TUMORS TO TREATMENT PCT PCT PCT/IL2020/050708 Expired
NCI E-152-2020-0-US-01 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST CD20 US 63/043,520 Abandoned
NCI E-239-2017-0-NZ-15 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS NZ National Stage 765440 Pending
NCATS E-757-2013-2-US-07 4-((2-HYDROXY-3-METHOXYBENZYL)AMINO) BENZENESULFONAMIDE DERIVATIVES AS 12-LIPOXYGENASE INHIBITORS US DIV 16/909,712 11274077 Issued PDF
NIAID E-188-2015-0-US-05 POLYMER ADJUVANT US CON 16/907,912 Abandoned
NEI E-284-2012-2-US-09 METHODS AND COMPOSITIONS FOR TREATING GENETICALLY LINKED DISEASES OF THE EYE US National Stage 16/956,976 Abandoned
NCATS E-136-2020-0-US-01 METHOTREXATE ANALOGS AND METHODS OF USE US 63/042,262 Abandoned
NCI E-021-2015-0-US-31 ANTI-CD70 CHIMERIC ANTIGEN RECEPTORS US DIV 16/906,061 11999796 Issued PDF
NIAID E-130-2020-0-US-01 HUMAN IGA MONOCLONAL ANTIBODY THAT TARGETS A CONSERVED SITE ON THE PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN US 63/041,439 Abandoned
NEI E-070-2019-0-PCT-02 INTERLEUKIN-27 PRODUCING B-CELLS AND USES THEREOF PCT PCT PCT/US2020/038368 Expired
NEI E-070-2019-0-EP-05 INTERLEUKIN-27 PRODUCING B-CELL POPULATION AND USES THEREOF EP National Stage 20736554.5 Pending